Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors Enzo ErrichettiAlen Zabotti Commentary Open access 30 November 2023 Pages: 1 - 3
Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice Anna BalatoFrancesca AmbrogioPaolo Gisondi Commentary Open access 02 December 2023 Pages: 5 - 13
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies Mitchell S. DavisRiley K. SpencerWilson Liao Review Open access 03 December 2023 Pages: 15 - 30
The Microbiome and Acne: Perspectives for Treatment Clio DessiniotiAndreas Katsambas Review Open access 06 January 2024 Pages: 31 - 44
Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review Sonja StänderThomas LugerGil Yosipovitch Review Open access 06 January 2024 Pages: 45 - 57
Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review Yao-Tsung YehTsen-Fang Tsai Review Open access 06 January 2024 Pages: 59 - 81
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes Alexa B. KimballJoslyn KirbyAmit Garg Review Open access 06 January 2024 Pages: 83 - 98
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan Yayoi TadaAhmed M. SolimanShinichi Imafuku Original Research Open access 29 November 2023 Pages: 99 - 114
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic Spyridon GkalpakiotisMartina KojanováPetr Arenberger Original Research Open access 30 November 2023 Pages: 115 - 130
Natural History of Keloids: A Sociodemographic Analysis Using Structured and Unstructured Data Anna SwensonJessica K. PaulusOladayo Jagun Original Research Open access 08 December 2023 Pages: 131 - 149
Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey Kouki NakamuraKazumasa KameiManabu Ohyama Original Research Open access 11 December 2023 Pages: 151 - 167
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis Kim RandJuan Manuel Ramos-GoñiJosé-Carlos Armario-Hita Original Research Open access 28 October 2023 Pages: 169 - 182
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis Kim RandJuan Manuel Ramos-GoñiJosé-Carlos Armario-Hita Correction Open access 20 January 2024 Pages: 183 - 185
Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population Mary E. HornerKate K. OrrothMyriam Cordey Original Research Open access 12 January 2024 Pages: 187 - 199
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis Leon KircikMatthew ZirwasAnna M. Tallman Original Research Open access 21 December 2023 Pages: 201 - 211
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study Norito KatohMasanori IkedaHidehisa Saeki Original Research Open access 21 December 2023 Pages: 213 - 232
Evaluation of a Novel Microfocused Ultrasound with Three‐Dimensional Digital Imaging for Facial Tightening: A Prospective, Randomized, Controlled Trial Jiafang ZhuYue HanXiaoxi Lin Original Research Open access 15 December 2023 Pages: 233 - 249
The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action Kathyana P. Santiago MangualSarah FerreeArianne Shadi Kourosh Brief Report Open access 16 December 2023 Pages: 251 - 259
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry Eric L. SimpsonBen LockshinAndrew Korotzer Brief Report Open access 04 January 2024 Pages: 261 - 270